Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISB vs SSNB+ICB for Shoulder Surgery
NCT07474896Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in shoulder osteoarthritis (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Incidence of Hemidiaphragmatic Paresis. Started Dec 2025; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
shoulder osteoarthritis
Beyond the preview
Go deeper on NCT07474896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07474896.